Soloway, M S <br/><br/>
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.  [electronic resource] 

 -  The Journal of urology  Aug 1996 
 - 363-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/00005392-199608000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--urine<br/>Carcinoma, Transitional Cell--diagnosis<br/>Confidence Intervals<br/>Cystoscopy<br/>Follow-Up Studies<br/>Humans<br/>Neoplasm Recurrence, Local--diagnosis<br/>Nuclear Proteins--urine<br/>Predictive Value of Tests<br/>ROC Curve<br/>Reagent Kits, Diagnostic<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Time Factors<br/>Urinary Bladder Neoplasms--diagnosis